Publications en collaboration avec des chercheurs de Hospital Clinic Barcelona (31)

2024

  1. Integrative single-cell expression and functional studies unravels a sensitization to cytarabine-based chemotherapy through HIF pathway inhibition in AML leukemia stem cells

    HemaSphere, Vol. 8, Núm. 2

  2. Molecular characterisation of lupus low disease activity state (LLDAS) and DORIS remission by whole-blood transcriptome-based pathways in a pan-European systemic lupus erythematosus cohort

    Annals of the Rheumatic Diseases, Vol. 83, Núm. 7, pp. 889-900

  3. Molecular subtypes explain lupus epigenomic heterogeneity unveiling new regulatory genetic risk variants

    npj Genomic Medicine, Vol. 9, Núm. 1

2023

  1. Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)

    Nature

2022

  1. Efficacy and safety of universal (TCRKO) ARI-0001 CAR-T cells for the treatment of B-cell lymphoma

    Frontiers in Immunology, Vol. 13

  2. Physiological lentiviral vectors for the generation of improved CAR-T cells

    Molecular Therapy - Oncolytics, Vol. 25, pp. 335-349

2021

  1. A new molecular classification to drive precision treatment strategies in primary Sjögren’s syndrome

    Nature Communications, Vol. 12, Núm. 1

  2. Engraftment characterization of risk-stratified AML in NSGS mice

    Blood Advances, Vol. 5, Núm. 23, pp. 4842-4854

  3. Integrative epigenomics in Sjögren´s syndrome reveals novel pathways and a strong interaction between the HLA, autoantibodies and the interferon signature

    Scientific Reports, Vol. 11, Núm. 1

  4. Mapping the human genetic architecture of COVID-19

    Nature, Vol. 600, Núm. 7889, pp. 472-477

  5. SD-OCT peripapillary nerve fibre layer and ganglion cell complex parameters in glaucoma: Principal component analysis

    British Journal of Ophthalmology, Vol. 105, Núm. 4, pp. 496-501

2020

  1. 41BB-based and CD28-based CD123-redirected T-cells ablate human normal hematopoiesis in vivo

    Journal for immunotherapy of cancer, Vol. 8, Núm. 1

  2. Genome-wide whole blood transcriptome profiling in a large European cohort of systemic sclerosis patients

    Annals of the Rheumatic Diseases, Vol. 79, Núm. 9, pp. 1218-1226

2019

  1. GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways

    Nature Communications, Vol. 10, Núm. 1

2018

  1. Detection of inflammatory monocytes but not mesenchymal stem/stromal cells in peripheral blood of patients with myelofibrosis

    British Journal of Haematology

  2. Sex Differences in Patients With Occult Cancer After Venous Thromboembolism

    Clinical and Applied Thrombosis/Hemostasis, Vol. 24, Núm. 3, pp. 489-495

  3. Validation of a prognostic score for hidden cancer in unprovoked venous thromboembolism

    PLoS ONE, Vol. 13, Núm. 3

2017

  1. A Genome-wide Association Study Identifies Risk Alleles in Plasminogen and P4HA2 Associated with Giant Cell Arteritis

    American Journal of Human Genetics, Vol. 100, Núm. 1, pp. 64-74

  2. Poly(ethylmethacrylate-co-diethylaminoethyl acrylate) coating improves endothelial re-population, bio-mechanical and anti-thrombogenic properties of decellularized carotid arteries for blood vessel replacement

    Scientific Reports, Vol. 7, Núm. 1

2014

  1. A genome-wide association study follow-up suggests a possible role for PPARG in systemic sclerosis susceptibility

    Arthritis Research and Therapy, Vol. 16, Núm. 1